Kristin Wynholds - Chief Product Officer at Better Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Product Officer
Issuer Symbol
BTTX
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kristin Wynholds since 10 Jan 2025

Holdings reported by Kristin Wynholds for Better Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 225,631 $38,335 $0.1699 18 Dec 2023 Direct
Stock Option (Right to Buy) 101,450 01 Mar 2023 Direct Common Stock

Transactions reported by Kristin Wynholds for Better Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.